• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于加速体内肝脏siRNA递送的维生素E支架pH敏感且可还原裂解的类脂质材料的分子调控

Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery.

作者信息

Akita Hidetaka, Noguchi Yuki, Hatakeyama Hiroto, Sato Yusuke, Tange Kota, Nakai Yuta, Harashima Hideyoshi

机构信息

Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Science, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, Japan.

NOF Corporation, 3-3 Chidori-cho, Kawasaki-ku, Kawasaki, Kanagawa 210-0865, Japan.

出版信息

ACS Biomater Sci Eng. 2015 Sep 14;1(9):834-844. doi: 10.1021/acsbiomaterials.5b00203. Epub 2015 Aug 20.

DOI:10.1021/acsbiomaterials.5b00203
PMID:33445261
Abstract

A lipid nanoparticle (LNP) composed of a series of SS-cleavable and pH-activated lipid-like materials (ssPalm) was previously developed as a platform of a gene delivery system. A tertiary amine and disulfide bonding were employed to destabilize the endosomal membrane and for intracellular collapse. We report herein on the development of a hepatocyte-targeting siRNA carrier by the molecular tuning of the hydrophobic scaffold, and tertiary amine structures. The gene knockdown activity against a hepatocyte-specific marker (factor VII: FVII) was improved when a more fat-soluble vitamin (vitamin E) was employed as a hydrophobic scaffold. Moreover, to allow the tertiary amines to accept protons by sensing a slight change in endosomal acidification, its structural flexibility was minimized by fixing it in a piperidine structure, and the distance between the surface of the particle to the ternary amine was increased. As a result, the p value was increased to the approximately 6.18 depending on its distance, while the p reached plateau when the tertiary amine was linked by an excess number of linear carbon chains. The pH-dependent membrane destabilization activity, as assessed by a hemolysis assay, was increased in parallel with the p value. Moreover, the gene knockdown activity was improved in parallel with hemolytic activity. Finally, further optimization of the lipid/siRNA ratio, and the use of chemically (2'-fluoro) modified siRNA synergistically improved the gene knockdown efficacy to an effective dose (ED) of 0.035 mg/kg. The developed ssPalm represents a promising platform for use as a hepatocyte-targeting siRNA carrier.

摘要

一种由一系列可被SS切割且对pH敏感的类脂质材料(ssPalm)组成的脂质纳米颗粒(LNP)先前已被开发为基因递送系统的平台。使用叔胺和二硫键来破坏内体膜的稳定性并实现细胞内崩解。我们在此报告通过对疏水支架和叔胺结构进行分子调控来开发一种肝细胞靶向性siRNA载体。当使用更具脂溶性的维生素(维生素E)作为疏水支架时,针对肝细胞特异性标志物(因子VII:FVII)的基因敲低活性得到了提高。此外,为了使叔胺能够通过感知内体酸化的轻微变化来接受质子,通过将其固定在哌啶结构中来最小化其结构灵活性,并增加颗粒表面到叔胺的距离。结果,根据其距离,p值增加到约6.18,而当叔胺通过过量的线性碳链连接时,p达到平台期。通过溶血试验评估的pH依赖性膜破坏活性与p值平行增加。此外,基因敲低活性与溶血活性平行提高。最后,进一步优化脂质/siRNA比例以及使用化学修饰(2'-氟)的siRNA协同将基因敲低功效提高到有效剂量(ED)为0.035 mg/kg。所开发的ssPalm是一种有前景的用作肝细胞靶向性siRNA载体的平台。

相似文献

1
Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery.用于加速体内肝脏siRNA递送的维生素E支架pH敏感且可还原裂解的类脂质材料的分子调控
ACS Biomater Sci Eng. 2015 Sep 14;1(9):834-844. doi: 10.1021/acsbiomaterials.5b00203. Epub 2015 Aug 20.
2
A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma.一种中性脂质包膜型纳米颗粒,由 pH 激活和维生素 E 支架脂质样材料组成,作为针对肾细胞癌的基因载体的平台。
J Control Release. 2015 Feb 28;200:97-105. doi: 10.1016/j.jconrel.2014.12.029. Epub 2014 Dec 24.
3
A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E-scaffold lipid-like material with the aid of an anti-inflammatory drug.一种基于细胞内环境敏感维生素 E 支架类脂质材料的肝内 pDNA 递送系统,辅以防炎药物。
J Control Release. 2018 Jun 10;279:262-270. doi: 10.1016/j.jconrel.2018.04.022. Epub 2018 Apr 17.
4
Development of an SS-Cleavable pH-Activated Lipid-Like Material (ssPalm) as a Nucleic Acid Delivery Device.开发一种 SS 可切割的 pH 激活型类脂质材料(ssPalm)作为核酸传递装置。
Biol Pharm Bull. 2020;43(11):1617-1625. doi: 10.1248/bpb.b20-00534.
5
Cellular environment-responsive nanomaterials for use in gene and siRNA delivery: molecular design for biomembrane destabilization and intracellular collapse.用于基因和 siRNA 递送的细胞环境响应性纳米材料:破坏生物膜和细胞内塌陷的分子设计。
Expert Opin Drug Deliv. 2016 Jul;13(7):1015-27. doi: 10.1517/17425247.2016.1154531. Epub 2016 Mar 21.
6
Neutral biodegradable lipid-envelope-type nanoparticle using vitamin A-Scaffold for nuclear targeting of plasmid DNA.使用维生素 A 支架的中性可生物降解脂质包膜型纳米颗粒,用于质粒 DNA 的核靶向。
Biomaterials. 2014 Feb;35(5):1755-61. doi: 10.1016/j.biomaterials.2013.11.016. Epub 2013 Nov 28.
7
A neutral envelope-type nanoparticle containing pH-responsive and SS-cleavable lipid-like material as a carrier for plasmid DNA.一种中性信封型纳米颗粒,包含 pH 响应和 SS 可切割的类脂质材料作为载体用于质粒 DNA。
Adv Healthc Mater. 2013 Aug;2(8):1120-5. doi: 10.1002/adhm.201200431. Epub 2013 Feb 6.
8
DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy.载 DNA 的纳米佐剂由维生素 E 支架细胞内环境响应性类脂材料形成,用于癌症免疫治疗。
Nanomedicine. 2018 Nov;14(8):2587-2597. doi: 10.1016/j.nano.2018.08.006. Epub 2018 Aug 29.
9
Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.了解 pH 敏感阳离子脂质的构效关系有助于合理鉴定有前途的用于体内递送 siRNA 的脂质纳米粒。
J Control Release. 2019 Feb 10;295:140-152. doi: 10.1016/j.jconrel.2019.01.001. Epub 2019 Jan 2.
10
Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.皮下给药后用于肝细胞基因沉默的 siRNA 的脂质纳米粒制剂的开发。
J Control Release. 2014 Dec 28;196:106-12. doi: 10.1016/j.jconrel.2014.09.025. Epub 2014 Oct 5.

引用本文的文献

1
Self-degradable "gemini-like" ionizable lipid-mediated delivery of siRNA for subcellular-specific gene therapy of hepatic diseases.用于肝脏疾病亚细胞特异性基因治疗的可自降解“类双子星”可电离脂质介导的siRNA递送
Acta Pharm Sin B. 2025 Jun;15(6):2867-2883. doi: 10.1016/j.apsb.2025.04.003. Epub 2025 Apr 6.
2
Prediction of the Apparent p Value of Lipid Nanoparticles by Density Functional Theory.基于密度泛函理论预测脂质纳米颗粒的表观p值
ACS Mater Au. 2025 Feb 27;5(3):451-457. doi: 10.1021/acsmaterialsau.4c00158. eCollection 2025 May 14.
3
A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.
一种基于脂质纳米颗粒的少突胶质细胞特异性mRNA疗法。
Mol Ther Nucleic Acids. 2024 Nov 5;35(4):102380. doi: 10.1016/j.omtn.2024.102380. eCollection 2024 Dec 10.
4
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses.一种带生育酚支架的可离子化脂质材料,作为一种 mRNA 疫苗平台,可有效诱导细胞毒性 T 细胞反应。
ACS Nano. 2023 Oct 10;17(19):18758-18774. doi: 10.1021/acsnano.3c02251. Epub 2023 Sep 26.
5
A Lipid Nanoparticle-Based Method for the Generation of Liver-Specific Knockout Mice.一种基于脂质纳米颗粒的生成肝脏特异性基因敲除小鼠的方法。
Int J Mol Sci. 2023 Sep 19;24(18):14299. doi: 10.3390/ijms241814299.
6
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases.用于疾病管理的小干扰RNA功能化脂质纳米颗粒(LNPs)
Pharmaceutics. 2022 Nov 19;14(11):2520. doi: 10.3390/pharmaceutics14112520.
7
pH-Responsive Lipid Nanoparticles Achieve Efficient mRNA Transfection in Brain Capillary Endothelial Cells.pH响应性脂质纳米颗粒在脑微血管内皮细胞中实现高效mRNA转染
Pharmaceutics. 2022 Jul 27;14(8):1560. doi: 10.3390/pharmaceutics14081560.
8
mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells.经系统免疫优化的 mRNA-LNP 疫苗通过激活脾脏免疫细胞诱导强烈的抗肿瘤免疫。
Mol Ther. 2022 Sep 7;30(9):3078-3094. doi: 10.1016/j.ymthe.2022.07.007. Epub 2022 Jul 12.
9
The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA.纳米医学释放信使核糖核酸无限应用潜力
Pharmaceutics. 2022 Feb 21;14(2):460. doi: 10.3390/pharmaceutics14020460.
10
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.三种已获批的 siRNA(Patisiran)和 mRNA(COVID-19 疫苗)药物中所采用的脂质纳米颗粒技术的差异。
Drug Metab Pharmacokinet. 2021 Dec;41:100424. doi: 10.1016/j.dmpk.2021.100424. Epub 2021 Oct 10.